Frontlight ResearchEarly access
Trial site
Lucerne
- 2running trials
- 3closed trials
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- Coronary artery disease2 trials
- Familial hypercholesterolaemia1 trial
- Lung cancer1 trial
- Multiple sclerosis1 trial
- Prostate cancer1 trial
- Stroke1 trial
- Phase
- Phase 34 trials
- Status
- Completed3 trials
- Active, not recruiting2 trials
- Lead sponsor
- Novartis Pharmaceuticals5 trials
Running trials
Closed trials
Recruiting
Completed
Kesimpta® (Ofatumumab) in Swiss Multiple Sclerosis Patients - an Observational Study
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026